Stocks and Investing
Stocks and Investing
Fri, September 21, 2018
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Thu, September 20, 2018
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Steve Beuchaw Initiated (BIO) at Hold and Held Target at $335 on, Sep 20th, 2018
Steve Beuchaw of Morgan Stanley, Initiated "Bio-Rad Laboratories, Inc." (BIO) at Hold and Held Target at $335 on, Sep 20th, 2018.
Steve has made no other calls on BIO in the last 4 months.
There are 2 other peers that have a rating on BIO. Out of the 2 peers that are also analyzing BIO, 1 agrees with Steve's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Jack Meehan of "Barclays" Initiated at Hold and Held Target at $345 on, Wednesday, September 5th, 2018
This is the rating of the analyst that currently disagrees with Steve
- Brandon Couillard of "Jefferies" Maintained at Strong Buy with Increased Target to $355 on, Wednesday, August 8th, 2018